ASTRAZENECA PLC 13D and 13G filings for ADC Therapeutics S.A.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 10:13 am Unchanged | 2023-12-31 | 13G | ADC Therapeutics S.A. ADCT | ASTRAZENECA PLC | 4,011,215 4.880% | 0 (Unchanged) | Filing |
| 2021-02-10 4:01 pm Purchase | 2020-05-11 | 13G | ADC Therapeutics S.A. ADCT | ASTRAZENECA PLC | 4,011,215 5.230% | 4,011,215 (New Position) | Filing |